Actavis, Inc. and the FDA agreed last week on a Consent Decree of Permanent Injunction, preventing the drug maker from distributing any products from their Actavis Totowa facility in New Jersey. This follows a series of manufacturing problems at the plant, including quality control problems which allowed oversized tablets of Digitek to be commercially released, resulting in hundreds of deaths and serious injuries. Continued
All Posts Tagged With: "Actavis Totowa"
Following Recalls, Digitek Manufacturer to Remain Shut Down
The U.S. Department of Justice and the FDA have taken steps to continue barring Actavis Totowa from manufacturing and distributing generic drugs. The actions were taken following a series of serious manufacturing problems which resulted in a nationwide Digitek recall earlier this year when double strength tablets were produced, and a subsequent recall that involved potential issues with over 65 different generic drugs. Continued
